CIK 0001600620
- Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981231763
- Phone
- +1 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- 4 Open-market sale Director sold 5,252 shares at $5.74 ($30,146)
- 4 Open-market sale Director sold 4,946 shares at $5.74 ($28,390)
- 4 Open-market sale Director sold 5,610 shares at $5.74 ($32,201)
- 4 Open-market sale Director sold 5,630 shares at $5.74 ($32,316)
- 4 Open-market sale Chief Executive Officer sold 126,981 shares at $5.60 ($711,094)
- 4 Open-market sale Chief Financial Officer sold 34,811 shares at $5.60 ($194,942)
- 4 Open-market sale EVP, Ops & Strategy sold 40,665 shares at $5.51 ($224,064)
- 4 Open-market sale Chief Commercial Officer sold 17,777 shares at $5.60 ($99,551)
- 4 Open-market sale EVP, General Counsel sold 57,745 shares at $5.60 ($323,372)
- 4 Open-market sale EVP, Research and Development sold 4,930 shares at $6.10 ($30,073)
- 4 Open-market sale EVP, Research and Development sold 25,146 shares at $5.48 ($137,800)
- 4 Open-market sale Chief Commercial Officer sold 15,867 shares at $5.48 ($86,951)
- 4 Grant or award EVP, Ops & Strategy acquired 216,666 shares (grant or award)
- 4 Grant or award EVP, General Counsel acquired 194,230 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 196,153 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 661,538 shares (grant or award)
- 4/A Open-market sale EVP, General Counsel sold 19,644 shares at $8.78 ($172,474)
- 4/A Open-market sale Chief Financial Officer sold 11,398 shares at $8.78 ($100,074)
- 4/A Open-market sale Chief Executive Officer sold 33,047 shares at $8.78 ($290,153)
- 4 Derivatives Options or other derivatives
Page 4 of 10 · 184 filings